JW (CAYMAN) THERAPEUTICS CO. LTD

Press Releases JW (Cayman) Therapeutics Co. Ltd

Equities

2126

KYG5210T1040

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-05-14 EDT			5-day change	1st Jan Change
2.57 ^HKD	+8.44%		+37.43%	+13.72%

03-20	JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023	MT
03-20	JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

WuXi Giant Nuo Announces Initiation of Clinical Study of JWATM214 for the Treatment of Advanced Hepatocellular Carcinoma	23-03-01	AQ
Medigene Receives $3 Million Milestone Payment from 2seventy bio	23-01-18	AQ
JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma	22-07-04	AQ
JW Therapeutics Announces IND Approval for the Pivotal Clinical Trial of Carteyva® in Second-line Large B-Cell Lymphoma	22-03-31	PR
JW Cayman Therapeutics : Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China	21-09-06	AQ
JW Therapeutics : Announces Strategic Partnership with MediTrust Health	21-08-20	PR
JW Cayman Therapeutics : CHANGE OF COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT	21-07-30	PU
JW Cayman Therapeutics : Form of proxy for the Annual General Meeting to be held on May 26, 2021	21-04-23	PU
JW Cayman Therapeutics : PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING	21-04-23	PU
JW Cayman Therapeutics : VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE SHARES OF THE COMPANY IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK CONNECT	21-03-15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW